Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Everolimus Tablets

Approval Number

国药准字H20253001

Company迪康倍（苏州）生物医药科技有限公司

Registration Date

January 2, 2025

Drug Information

Generic Name

依维莫司片

Dosage Form

片剂

Strength

5mg

Drug Type

化学药品

Registration Date

January 2, 2025

Company Information

Applicant Company

Company Name迪康倍（苏州）生物医药科技有限公司

Company Address

中国（江苏）自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期B2楼707D单元

Manufacturing Company

Company Name博瑞制药（苏州）有限公司

Company Address

苏州工业园区星湖街218号C25楼、C26楼、C28楼

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy